ScholarIQanswers from OpenAlex
Teprotumumab for Thyroid-Associated Ophthalmopathy
PaperCitations, authors & open-access status
Teprotumumab for Thyroid-Associated Ophthalmopathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Teprotumumab for Thyroid-Associated Ophthalmopathy have?
ScholarIQcitation count
Teprotumumab for Thyroid-Associated Ophthalmopathy has 733 citations in the OpenAlex counts ScholarIQ stores.
When was Teprotumumab for Thyroid-Associated Ophthalmopathy published?
ScholarIQyear
Teprotumumab for Thyroid-Associated Ophthalmopathy has 2017 year in the ScholarIQ index.
What is the open-access status of Teprotumumab for Thyroid-Associated Ophthalmopathy?
ScholarIQoa status
Teprotumumab for Thyroid-Associated Ophthalmopathy has bronze oa status in the ScholarIQ index.
What is the DOI of Teprotumumab for Thyroid-Associated Ophthalmopathy?
ScholarIQdoi
The DOI for Teprotumumab for Thyroid-Associated Ophthalmopathy is on the source record.
What is the PMID of Teprotumumab for Thyroid-Associated Ophthalmopathy?
ScholarIQpmid
The PMID for Teprotumumab for Thyroid-Associated Ophthalmopathy is on the source record.
What is the OpenAlex record for Teprotumumab for Thyroid-Associated Ophthalmopathy?
ScholarIQopenalex
The OpenAlex for Teprotumumab for Thyroid-Associated Ophthalmopathy is on the source record.